Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Abgenix Inc.

Headquarters: Fremont, CA, United States of America
Website: N/A
Year Founded: 1996
Status: Acquired

BioCentury | Oct 25, 2014
Company News

Venture Tracks

BioCentury | May 12, 2014
Company News

Amgen, ImmunoGen, Oxford BioTherapeutics deal

BioCentury | Oct 14, 2013
Strategy

Reviving Merck

Why it will take years to see Perlmutter's effect on R&D at Merck
BioCentury | Dec 24, 2012
Company News

Amgen, ImmunoGen deal

BioCentury | Feb 27, 2012
Emerging Company Profile

Kymab: More mAb diversity

Wellcome backing Kymab's Kymouse to create diverse human antibodies
BioCentury | Nov 21, 2011
Company News

Amgen, ImmunoGen deal

BioCentury | Nov 7, 2011
Company News

Amgen, ImmunoGen deal

BioCentury | Feb 17, 2011
Targets & Mechanisms

EMMPRIN's new clothes

BioCentury | Jan 31, 2011
Strategy

Selling mouse futures

Ablexis, investors using open licensing model for quick ROI from AlivaMab mouse
BioCentury | Jan 24, 2011
Company News

Amgen, Boehringer Ingelheim deal

Items per page:
1 - 10 of 334